JP2009543885A5 - - Google Patents

Download PDF

Info

Publication number
JP2009543885A5
JP2009543885A5 JP2009520962A JP2009520962A JP2009543885A5 JP 2009543885 A5 JP2009543885 A5 JP 2009543885A5 JP 2009520962 A JP2009520962 A JP 2009520962A JP 2009520962 A JP2009520962 A JP 2009520962A JP 2009543885 A5 JP2009543885 A5 JP 2009543885A5
Authority
JP
Japan
Prior art keywords
dosage form
ibuprofen
famotidine
unit dosage
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009520962A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009543885A (ja
Filing date
Publication date
Priority claimed from US11/489,269 external-priority patent/US20080021078A1/en
Priority claimed from US11/489,272 external-priority patent/US20080020040A1/en
Application filed filed Critical
Priority claimed from PCT/US2007/073716 external-priority patent/WO2008011426A2/en
Publication of JP2009543885A publication Critical patent/JP2009543885A/ja
Publication of JP2009543885A5 publication Critical patent/JP2009543885A5/ja
Pending legal-status Critical Current

Links

JP2009520962A 2006-07-18 2007-07-17 イブプロフェンの投与のための方法および医薬 Pending JP2009543885A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/489,269 US20080021078A1 (en) 2006-07-18 2006-07-18 Methods and medicaments for administration of ibuprofen
US11/489,272 US20080020040A1 (en) 2006-07-18 2006-07-18 Unit dose form for administration of ibuprofen
US89737107P 2007-01-24 2007-01-24
PCT/US2007/073716 WO2008011426A2 (en) 2006-07-18 2007-07-17 Methods and medicaments for administration of ibuprofen

Publications (2)

Publication Number Publication Date
JP2009543885A JP2009543885A (ja) 2009-12-10
JP2009543885A5 true JP2009543885A5 (https=) 2011-08-11

Family

ID=38957561

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009520962A Pending JP2009543885A (ja) 2006-07-18 2007-07-17 イブプロフェンの投与のための方法および医薬

Country Status (13)

Country Link
EP (2) EP2043637B8 (https=)
JP (1) JP2009543885A (https=)
AT (1) ATE539747T1 (https=)
AU (1) AU2007275360B2 (https=)
BR (1) BRPI0714937A2 (https=)
CA (1) CA2657928C (https=)
DK (1) DK2043637T3 (https=)
ES (1) ES2380747T3 (https=)
IL (1) IL196425A (https=)
NZ (1) NZ574200A (https=)
PL (1) PL2043637T3 (https=)
PT (1) PT2043637E (https=)
WO (1) WO2008011426A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8067451B2 (en) 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
WO2008091957A2 (en) * 2007-01-24 2008-07-31 Horizon Therapeutics, Inc. Pharmaceutical compositions containing famotidine and ibuprofen and having improved content uniformity
WO2013054352A1 (en) 2011-08-17 2013-04-18 Cadila Healthcare Limited Pharmaceutical compositions of ibuprofen and famotidine
CA2889711A1 (en) 2012-10-29 2014-05-08 Arizona Board Of Regents On Behalf Of University Of Arizona Predictive markers for polyamine inhibitor cancer therapies
WO2015163832A1 (en) 2014-04-25 2015-10-29 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. An ibuprofen and famotidine combined composition having improved stability
WO2015195120A1 (en) 2014-06-18 2015-12-23 Arizona Board Of Regents On Behalf Of University Of Arizona Carcinoma diagnosis and treatment based on odc1 genotype
WO2016130918A1 (en) 2015-02-12 2016-08-18 The Arizona Board Of Regents On Behalf Of The University Of Arizona Methods for treating neuroblastoma
WO2017075576A1 (en) * 2015-10-30 2017-05-04 Cancer Prevention Pharmaceuticals, Inc. Eflornithine and sulindac, fixed dose combination formulation
KR20260033630A (ko) 2015-10-30 2026-03-10 캔서 프리벤션 파마수티컬스, 인코포레이티드 에플로르니틴 및 설린닥, 고정된 용량 조합 제제
JP2022532766A (ja) 2019-05-17 2022-07-19 キャンサー プリベンション ファーマシューティカルズ,インコーポレイテッド 家族性腺腫性ポリポーシスを処置するための方法
EP4181912A1 (en) * 2020-07-15 2023-05-24 Schabar Research Associates LLC Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn
US12514846B2 (en) 2020-07-15 2026-01-06 Schabar Research Associates Llc Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach
CA3124579C (en) 2020-07-15 2026-03-31 Schabar Research Associates Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
WO2023068839A1 (ko) * 2021-10-21 2023-04-27 한화제약주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 안정성이 개선된 필름코팅 정제

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056143B2 (ja) 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法
US4543370A (en) 1979-11-29 1985-09-24 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4802924A (en) 1986-06-19 1989-02-07 Colorcon, Inc. Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products
HU196775B (en) 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
CA2144155A1 (en) * 1992-09-29 1994-04-14 Robert T. Sims Ibuprofen-h2 antagonist combinations
US5976578A (en) * 1996-10-10 1999-11-02 Mcneil-Ppc, Inc. Liquid antacid compositions
US6251945B1 (en) 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
DE10003757A1 (de) 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
EP2260837A1 (en) * 2001-06-01 2010-12-15 Pozen, Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
DE10153934A1 (de) 2001-11-06 2003-05-22 Basf Ag Verfahren zur Kristallisation von Profenen
CA2554012A1 (en) * 2003-01-21 2004-08-05 Smartrix Technologies Inc. Oral dosage formulation
JP2006076956A (ja) * 2004-09-10 2006-03-23 Taiyo Yakuhin Kogyo Kk 胃炎の治療・予防用配合剤
WO2007012019A2 (en) * 2005-07-18 2007-01-25 Horizon Therapeutics, Inc. Medicaments containing famotidine and ibuprofen and administration of same
DE102005049001A1 (de) 2005-10-11 2007-04-12 Basf Ag Verfahren zur Herstellung von direkttablettierbaren Ibuprofen-Formulierungen

Similar Documents

Publication Publication Date Title
JP2009543885A5 (https=)
JP2006504795A5 (https=)
JP2022180461A5 (https=)
JP2009536147A5 (https=)
JP2010525050A5 (https=)
JP2013231087A5 (https=)
JP2012031131A5 (https=)
MX2009000730A (es) Liberacion controlada de formulaciones y metodos asociados.
JP2009501801A5 (https=)
HRP20130057T1 (hr) Lijeäśenje progresivne neurodegenerativne bolesti ibudilastom
JP2012515184A5 (https=)
JP2013505205A5 (https=)
JP2009525985A5 (https=)
Bhaskar et al. Comparison of transdermal diclofenac patch with oral diclofenac as an analgesic modality following multiple premolar extractions in orthodontic patients: a cross over efficacy trial
JP2012500786A5 (https=)
JP2011527301A5 (https=)
JP2019517542A5 (https=)
CA2570474A1 (en) A combination composition comprising paracetamol and ibuprofen
JP2013541583A5 (https=)
JP2013544290A5 (https=)
JP2012533559A5 (https=)
AR105184A1 (es) Comprimidos de liberación inmediata que contienen un fármaco y procesos para formar los comprimidos
Schadt Topical and oral bexarotene
HRP20161470T1 (hr) Smjese flurbiprofena s kontroliranim otpuštanjem i mišićnog relaksanta
JP2005517040A5 (https=)